Kyoto, Japan

Megakaryon Corporation


USPTO Granted Patents = 13


Forward Citations = 4

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Koji Eto (8 out of 43 patents)

silverMedal Yukitaka Ito (7 out of 7 patents)

bronzeMedal Tomohiro Shigemori (5 out of 5 patents)

4.  Haruki Okamoto (4 out of 4 patents)

5.  Sou Nakamura (4 out of 8 patents)

6.  Hideya Seo (3 out of 3 patents)

7.  Akira Ota (3 out of 7 patents)

8.  Yasuko Hazama (3 out of 3 patents)

9.  Hiroshi Endo (2 out of 2 patents)

10.  Takeaki Dohda (2 out of 2 patents)

11.  Hidenori Hirose (2 out of 2 patents)

12.  Yoshikazu Kato (2 out of 5 patents)

13.  Junichi Fukunaga (1 out of 1 patent)

14.  Michiko Ueda (1 out of 1 patent)

15.  Junko Tomizuka (1 out of 1 patent)


13 patents:

Company Overview
Megakaryon Corporation is a biotechnology firm based in Kyoto, Japan, specializing in the development of innovative cell therapy solutions. The company focuses on harnessing the potential of megakaryocytes, a type of bone marrow cell, to create advanced therapeutic products aimed at treating various diseases. With a strong emphasis on research and development, Megakaryon is at the forefront of regenerative medicine, contributing to the evolving landscape of healthcare through its pioneering technologies and collaborative efforts in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#111 in Kyoto 615-0031

#3,749 in Japan

#45,039 in the World

Kyoto, JP
Kyoto, Japan
Forward Citations = 4

25 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Megakaryon Corporation. Retrieved from https://idiyas.com/company/megakaryon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…